OTCPK:MEDVF - Post by User
Post by
Sarb99on Feb 01, 2021 1:12pm
135 Views
Post# 32437713
Collection Sites’ COVID-19 testing network and recent sales
Collection Sites’ COVID-19 testing network and recent sales Specifically, the webinar will feature Medivolve CEO Doug Sommerville and Collection Sites, LLC President Tim Shelburn who will discuss the growth of Collection Sites’ COVID-19 testing network and recent sales performance. It will also feature a special presentation from the UCLA-based research team behind Marvel Diagnostics and its novel technology. Medivolve has signed a share purchase agreement to acquire up to 40% of Marvel Diagnostics Inc, for an aggregate price of up to US$1 million through a series of milestone-based payments. This funding will be used to complete clinical studies for the BlowFISH collection system and to design and optimize, manufacture and market the device. Registration Link: https://us02web.zoom.us/webinar/register/WN_MwefnnmjR2y4mZb7xJq-ZA